Puerperal hypertension, stroke, and seizures after suppression of lactation with bromocriptine.
The "absolute safety" of bromocriptine as a drug of choice in suppression of lactation is questioned. Two cases of cerebrovascular events after the use of bromocriptine for lactation suppression are presented, and the available, pertinent literature is reviewed.
D000328:Adult; D001971:Bromocriptine / Q000009:adverse effects* / Q000494:pharmacology; D002561:Cerebrovascular Disorders / Q000139:chemically induced*; D005260:Female; D006801:Humans; D006973:Hypertension / Q000139:chemically induced*; D007231:Infant, Newborn; D007774:Lactation / Q000187:drug effects*; D008297:Male; D011247:Pregnancy; D011644:Puerperal Disorders / Q000139:chemically induced*; D012640:Seizures / Q000139:chemically induced*
D001971:Bromocriptine